Lucy Akushevich

2.2k total citations
38 papers, 1.4k citations indexed

About

Lucy Akushevich is a scholar working on Hepatology, Epidemiology and Reproductive Medicine. According to data from OpenAlex, Lucy Akushevich has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hepatology, 11 papers in Epidemiology and 9 papers in Reproductive Medicine. Recurrent topics in Lucy Akushevich's work include Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Ovarian cancer diagnosis and treatment (9 papers). Lucy Akushevich is often cited by papers focused on Hepatitis C virus research (13 papers), Liver Disease Diagnosis and Treatment (11 papers) and Ovarian cancer diagnosis and treatment (9 papers). Lucy Akushevich collaborates with scholars based in United States, Germany and Canada. Lucy Akushevich's co-authors include Konstantin G. Arbeev, Svetlana Ukraintseva, Igor Akushevich, Joellen M. Schildkraut, Anatoli I. Yashin, Alexander M. Kulminski, Andrew Berchuck, Patricia G. Moorman, Michael Fried and Monika Vainorius and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Lucy Akushevich

38 papers receiving 1.3k citations

Peers

Countries citing papers authored by Lucy Akushevich

Since Specialization

Citations

This map shows the geographic impact of Lucy Akushevich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Akushevich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Akushevich more than expected).

Fields of papers citing papers by Lucy Akushevich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Akushevich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Akushevich. The network helps show where Lucy Akushevich may publish in the future.

Co-authorship network of co-authors of Lucy Akushevich

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy Akushevich. A scholar is included among the top collaborators of Lucy Akushevich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy Akushevich. Lucy Akushevich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET study 2023 ·American Journal of Transplantation ·Wesam Aleyadeh, Elizabeth C. Verna, Hany Elbeshbeshy, Mark Sulkowski, Coleman I. Smith, Jama M. Darling, Richard K. Sterling, Andrew J. Muir, Lucy Akushevich, (unknown), Norah A. Terrault, Michael Fried, Jordan J. Feld	3
2	DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort 2020 ·Journal of Hepatology ·Elizabeth C. Verna, Giuseppe Morelli, Norah A. Terrault, Anna S. Lok, Joseph K. Lim, Adrian M. Di Bisceglie, Stefan Zeuzem, Charles Landis, Paul Y. Kwo, Mohamed A. Hassan, Michael P. Manns, Monika Vainorius, Lucy Akushevich, David R. Nelson, Michael Fried, K. Rajender Reddy	81
3	Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients With Genotype 1 Hepatitis C Virus Infection and Cirrhosis 2018 ·Clinical Gastroenterology and Hepatology ·Joseph K. Lim, (unknown), Mitchell L. Shiffman, Anna S. Lok, Stefan Zeuzem, Norah A. Terrault, James Park, Charles Landis, Mohamed A. Hassan, Joel E. Gallant, Alexander Kuo, Paul J. Pockros, Monika Vainorius, Lucy Akushevich, (unknown), Michael Fried, David R. Nelson, Ziv Ben‐Ari	13
4	Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET study 2016 ·Gut ·Tania M. Welzel, David R. Nelson, Giuseppe Morelli, Adrian M. Di Bisceglie, K. Rajender Reddy, Alexander Kuo, Joseph K. Lim, Jama M. Darling, Paul J. Pockros, Joseph Galati, Lynn M. Frazier, Saleh A. Alqahtani, Mark Sulkowski, Monika Vainorius, Lucy Akushevich, Michael Fried, Stefan Zeuzem	61
5	Open-Label Study to Evaluate the Safety & Tolerability of Telaprevir in Combination With Sofosbuvir in Naive Subjects Infected With Hepatitis C Virus Genotype 1 2015 ·Journal of Gastroenterology and Hepatology Research ·Giuseppe Morelli, Roberto J. Firpi, (unknown), (unknown), Lucy Akushevich, (unknown), Shelley George, Alejandro de la Rosa, (unknown), (unknown), Richard F. Arrendale, Tara L. Kieffer, Varun Garg, Michael Fried, David R. Nelson	1
6	A multi-center population-based case–control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES) 2014 ·BMC Cancer ·Joellen M. Schildkraut, Anthony J. Alberg, Elisa V. Bandera, Jill S. Barnholtz‐Sloan, Melissa L. Bondy, Michelle L. Cote, Ellen Funkhouser, Edward Peters, Ann G. Schwartz, Paul Terry, Kristin Wallace, Lucy Akushevich, Frances Wang, (unknown), Patricia G. Moorman	59
7	Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues 2012 ·Gynecologic Oncology ·(unknown), Edwin S. Iversen, Regina S. Whitaker, Lucy Akushevich, Joellen M. Schildkraut, Susan K. Murphy, Jeffrey R. Marks, Andrew Berchuck	18
8	Medical Cost Trajectories and Onsets of Cancer and NonCancer Diseases in US Elderly Population 2011 ·Computational and Mathematical Methods in Medicine ·Igor Akushevich, Julia Kravchenko, Lucy Akushevich, Svetlana Ukraintseva, Konstantin G. Arbeev, Anatoliy I. Yashin	16
9	Age trajectories of physiological indices in relation to healthy life course 2011 ·Mechanisms of Ageing and Development ·Konstantin G. Arbeev, Svetlana Ukraintseva, Igor Akushevich, Alexander M. Kulminski, Liubov Arbeeva, Lucy Akushevich, Irina Culminskaya, Anatoliy I. Yashin	61
10	Recreational Physical Activity and Ovarian Cancer Risk and Survival 2011 ·Annals of Epidemiology ·Patricia G. Moorman, Lee W. Jones, Lucy Akushevich, Joellen M. Schildkraut	51
11	Loss of ARID1A-Associated Protein Expression is a Frequent Event in Clear Cell and Endometrioid Ovarian Cancers 2011 ·International Journal of Gynecological Cancer ·William J. Lowery, Joellen M. Schildkraut, Lucy Akushevich, Rex C. Bentley, Jeffrey R. Marks, David G. Huntsman, Andrew Berchuck	77
12	Primary peritoneal and ovarian cancers: an epidemiological comparative analysis 2010 ·Cancer Causes & Control ·Delores J. Grant, Patricia G. Moorman, Lucy Akushevich, Rachel T. Palmieri, Rex C. Bentley, Joellen M. Schildkraut	18
13	Studying health histories of cancer: A new model connecting cancer incidence and survival 2009 ·Mathematical Biosciences ·Anatoli I. Yashin, Igor Akushevich, Konstantin G. Arbeev, Lucy Akushevich, Alexander M. Kulminski, Svetlana Ukraintseva	6
14	Ovarian Cancer Risk Factors in African-American and White Women 2009 ·American Journal of Epidemiology ·Patricia G. Moorman, Rachel T. Palmieri, Lucy Akushevich, Andrew Berchuck, Joellen M. Schildkraut	88
15	Cumulative Deficits and Physiological Indices as Predictors of Mortality and Long Life 2008 ·The Journals of Gerontology Series A ·Alexander M. Kulminski, Svetlana Ukraintseva, Irina Culminskaya, Konstantin G. Arbeev, Kenneth C. Land, Lucy Akushevich, Anatoliy I. Yashin	46
16	What age trajectories of cumulative deficits and medical costs tell us about individual aging and mortality risk: Findings from the NLTCS-Medicare data 2008 ·Mechanisms of Ageing and Development ·Anatoli I. Yashin, Konstantin G. Arbeev, Alexander M. Kulminski, Igor Akushevich, Lucy Akushevich, Svetlana Ukraintseva	21
17	Health decline, aging and mortality: how are they related? 2007 ·Biogerontology ·Anatoli I. Yashin, Konstantin G. Arbeev, (unknown), Igor Akushevich, Lucy Akushevich, Svetlana Ukraintseva	52
18	Model of hidden heterogeneity in longitudinal data 2007 ·Theoretical Population Biology ·Anatoli I. Yashin, Konstantin G. Arbeev, Igor Akushevich, Alexander M. Kulminski, Lucy Akushevich, Svetlana Ukraintseva	20
19	Stochastic model for analysis of longitudinal data on aging and mortality 2006 ·Mathematical Biosciences ·Anatoli I. Yashin, Konstantin G. Arbeev, Igor Akushevich, (unknown), Lucy Akushevich, Svetlana Ukraintseva	54
20	Insights on aging and exceptional longevity from longitudinal data: novel findings from the Framingham Heart Study 2006 ·AGE ·Anatoli I. Yashin, Igor Akushevich, Konstantin G. Arbeev, Lucy Akushevich, Svetlana Ukraintseva, (unknown)	46

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact